KLF4 Antibody Blocking Peptide

Product Discontinued

KLF4 Antibody Blocking Peptide Summary

• Description: A blocking peptide containing 20 amino acids near the carboxy terminus of carboxy terminus of human KLF4.

  Source: Synthetic

  (Accession #: AAH30811)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: KLF4
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-77382.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• Preservative: 0.02% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: N/A

Alternate Names for KLF4 Antibody Blocking Peptide

• Epithelial zinc finger protein EZF
• EZF
• EZFendothelial Kruppel-like zinc finger protein
• GKLFKrueppel-like factor 4
• Gut-enriched krueppel-like factor
• KLF4
• Kruppel-like factor 4 (gut)

Background

KLF4 is a transcription factor that works with Sp1 to activate the Laminin gamma1 chain gene. It binds the CACCC core sequence. KLF4 may be involved in the differentiation of epithelial cells and may also function in the development of the skeleton and kidney. KLF4 also has roles as both an oncogene and a tumor suppressor.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: KLF4